Logo image of MDXH

MDXHEALTH (MDXH) Stock Earnings & Estimates

USA - NASDAQ:MDXH - BE0974461940 - Common Stock

3.64 USD
-0.33 (-8.31%)
Last: 11/14/2025, 8:00:56 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
MDXH revenue by date.MDXH revenue by date.
37.05M
66.59%
70.193M
89.45%
90.049M
28.29%
112.36M
24.78%
136.18M
21.20%
167.74M
23.18%
222.84M
32.85%
EBITDA
YoY % growth
MDXH ebitda by date.MDXH ebitda by date.
-32.95M
-38.45%
-20.468M
37.88%
-16.683M
18.49%
2.04M
112.23%
12.104M
493.33%
28.101M
132.16%
39.877M
41.91%
EBIT
YoY % growth
MDXH ebit by date.MDXH ebit by date.
-37.86M
-41.06%
-27.327M
27.82%
-24.722M
9.53%
-9.678M
60.85%
2.226M
123.00%
11.424M
413.21%
27.537M
141.05%
Operating Margin
MDXH operating margin by date.MDXH operating margin by date.
-102.19%-38.93%-27.45%-8.61%1.63%6.81%12.36%
EPS
YoY % growth
MDXH eps by date.MDXH eps by date.
-0.82
64.36%
-1.59
-94.65%
-1.27
20.13%
-0.51
59.84%
-0.26
48.40%
0.00
100.00%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.13
8.20%
-0.10
47.66%
-0.09
42.20%
-0.07
56.97%
-0.03
76.19%
Revenue
Q2Q % growth
31.151M
25.92%
32.309M
33.00%
33.354M
25.37%
35.216M
28.37%
38.25M
22.79%
EBITDA
Q2Q % growth
1.403M
152.72%
1.326M
156.64%
3.74M
287.85%
3.808M
918.17%
10.71M
663.36%
EBIT
Q2Q % growth
-2.27M
78.79%
-2.754M
39.97%
-357K
94.51%
-561K
73.49%
3.876M
270.79%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.16
60.00%
-0.11-0.05-45.24%
Q2 2025
Q2Q % growth
-0.15
64.29%
-0.13-0.02-18.60%
Q1 2025
Q2Q % growth
-0.19
38.71%
-0.13-0.06-43.29%
Q4 2024
Q2Q % growth
-0.14
64.10%
-0.200.0628.51%
Q3 2024
Q2Q % growth
-0.40 -0.28-0.12-45.24%
Q2 2024
Q2Q % growth
-0.42
-40.00%
-0.27-0.15-55.38%
Q1 2024
Q2Q % growth
-0.31
38.00%
-0.310.00-1.31%
Q4 2023
Q2Q % growth
-0.39
64.55%
-0.11-0.28-247.59%
Q3 2023
Q2Q % growth
-0.40
2.06%
-0.20-0.20-104.25%
Q2 2023
Q2Q % growth
-0.30 -0.22-0.08-34.92%
Q1 2023
Q2Q % growth
-0.50
-22.42%
-0.33-0.17-52.00%
Q4 2022
Q2Q % growth
-1.10 -0.67-0.43-65.07%
Q3 2022
Q2Q % growth
-0.41 -5.415.0092.45%
Q2 2020
Q2Q % growth
-1.80 -1.63-0.17-10.29%
MDXH Yearly EPS VS EstimatesMDXH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
27.433M
17.65%
28.689M-1.256M-4.38%
Q2 2025
Q2Q % growth
26.605M
20.06%
26.842M-237K-0.88%
Q1 2025
Q2Q % growth
24.292M
22.48%
24.551M-259K-1.05%
Q4 2024
Q2Q % growth
24.739M
27.53%
23.827M912K3.83%
Q3 2024
Q2Q % growth
23.317M
20.50%
21.91M1.407M6.42%
Q2 2024
Q2Q % growth
22.159M
32.33%
21.236M923K4.35%
Q1 2024
Q2Q % growth
19.834M
34.93%
18.574M1.26M6.78%
Q4 2023
Q2Q % growth
19.398M
-19.34%
18.499M899K4.86%
Q3 2023
Q2Q % growth
19.35M
73.48%
18.354M996K5.43%
Q2 2023
Q2Q % growth
16.745M
28.71%
15.455M1.29M8.35%
Q1 2023
Q2Q % growth
14.7M 13.663M1.037M7.59%
Q4 2022
Q2Q % growth
24.05M
108.95%
12.58M11.47M91.18%
Q3 2022
Q2Q % growth
11.154M 9.761M1.393M14.27%
Q2 2022
Q2Q % growth
13.01M
21.25%
%
Q4 2021
Q2Q % growth
11.51M
34.15%
%
Q2 2021
Q2Q % growth
10.73M
8.60%
%
Q4 2020
Q2Q % growth
8.58M
842.86%
%
Q2 2020
Q2Q % growth
9.88M
-9.11%
11.883M-2.003M-16.86%
MDXH Yearly Revenue VS EstimatesMDXH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -1.89% 3.47% -5.04%
Revenue0% 0.19% 0.28% 1.11%